Document Detail


Significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change.
MedLine Citation:
PMID:  8726546     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We investigated the effect of carbamazepine (CBZ) cotreatment with haloperidol (HP) on cardiac change in Japanese psychiatric patients without heart disease. Of 21 patients cotreated with CBZ, 11 showed lengthening of QT interval corrected for heart rate (QTc) (> 440, mean percentage change, 29), of whom two patients developed congestive heart failure because of left ventricular dysfunction. Especially in these two patients, plasma HP levels were significantly higher than speculated from the correlations. It is possible to speculate that, especially on CBZ cotreatment, significantly higher HP plasma level with QTc prolongation may herald heart failure.
Authors:
K Iwahashi
Related Documents :
10392876 - Prolonged qt interval and altered qt/rr relation early after radiofrequency ablation of...
2722286 - Rate-dependent change in dispersion of repolarisation during ventricular pacing in man.
11132166 - Qt interval dispersion: non-invasive marker of ischemic injury in patients with unstabl...
16309926 - Is primidone the drug of choice for epileptic patients with qt-prolongation? a comprehe...
2000756 - Extraction of implanted transvenous pacing leads: a review of a persistent clinical pro...
2002686 - Efficacy of percutaneous mitral balloon valvuloplasty with the inoue balloon.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical neuropharmacology     Volume:  19     ISSN:  0362-5664     ISO Abbreviation:  Clin Neuropharmacol     Publication Date:  1996 Jun 
Date Detail:
Created Date:  1996-11-27     Completed Date:  1996-11-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7607910     Medline TA:  Clin Neuropharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  267-70     Citation Subset:  IM    
Affiliation:
Department of Neuropsychiatry, Kagawa Medical School, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Anticonvulsants / administration & dosage,  adverse effects*
Antipsychotic Agents / administration & dosage,  adverse effects*,  blood
Carbamazepine / administration & dosage,  adverse effects*
Drug Therapy, Combination
Electrocardiography
Female
Haloperidol / administration & dosage,  adverse effects*,  blood
Heart Failure / chemically induced
Humans
Long QT Syndrome / chemically induced*
Male
Middle Aged
Schizophrenia / drug therapy*
Ventricular Dysfunction, Left / chemically induced
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0/Antipsychotic Agents; 298-46-4/Carbamazepine; 52-86-8/Haloperidol
Comments/Corrections
Comment In:
Clin Neuropharmacol. 1997 Apr;20(2):179   [PMID:  9099473 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient.
Next Document:  Abnormalities of antioxidant metabolism in a case of Friedreich's disease.